表达弓形虫ROP18与MIC8的病毒样颗粒疫苗提供增强保护
研究用表达弓形虫棒状体蛋白18(ROP18)和微线体蛋白8(MIC8)的病毒样颗粒(VLP)疫苗单独或联合经鼻免疫小鼠,随后分别以GT1速殖子腹腔注射或ME49经口感染攻击;联合VLP疫苗较单一VLP疫苗诱导更强的寄生虫中和活性、记忆T细胞应答并降低虫负荷,攻击后炎症细胞因子(IFN-γ、IL-6)与凋亡反应更低,提示VLP平台可开发为弓形虫病候选疫苗。
要点
- 联合ROP18与MIC8 VLP较单一VLP诱导更强中和活性与记忆T细胞应答。
- 联合VLP组攻击后虫负荷更低,炎症细胞因子与凋亡反应更低。
- 作者认为VLP平台可开发为抗弓形虫病候选疫苗。
核心结论
- VLP疫苗同时呈现弓形虫ROP18与MIC8抗原较单一VLP疫苗提供增强保护,VLP平台可开发为抗弓形虫病候选疫苗。
研究设计与样本
- 小鼠经鼻免疫单一ROP18 VLP、单一MIC8 VLP或ROP18 VLP与MIC8 VLP联合,随后以弓形虫GT1速殖子腹腔注射或ME49经口感染攻击。
主要发现
- 联合ROP18 VLP与MIC8 VLP较单一VLP疫苗在诱导寄生虫中和活性、记忆T细胞应答及降低虫负荷方面作用更强。
- 联合VLP疫苗组攻击后观察到较低水平的炎症细胞因子(IFN-γ、IL-6)和凋亡反应。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Toxoplasma gondii rhoptry protein 18 (ROP18) and microneme protein 8 (MIC8) are important invasion factors that mediate parasite multiplication. The main objective of this study was to determine the immunogenicity and efficacy by virus-like particle (VLP) vaccines of T. gondii ROP18 VLPs and MIC8 VLPs in combination or individuals. Mice were intranasally immunized with single ROP18 VLPs or MIC8 VLPs, or a combination of ROP18 VLPs and MIC8 VLPs followed by challenge with T. gondii tachyzoites (GT1) through intraperitoneal injection or challenge with T. gondii (ME49) through oral infection. Vaccination with a combination of ROP18 VLPs and MIC8 VLPs resulted in more potent effects on inducing parasite neutralizing activity, memory T cell response, and reducing parasite burden compared to single VLP vaccination. Lower levels of inflammatory cytokines (IFN-γ, IL-6) and apoptosis responses were observed with VLP vaccine combination after challenge. These results suggest that VLP vaccines presenting both T. gondii ROP18 and MIC8 antigens confer enhanced protection compared to a single VLPs vaccine, and VLP platforms could be developed as potential vaccines against toxoplasmosis.
引用
- Lee SH, Kang HJ, Lee DH, et al. Virus-like particle vaccines expressing Toxoplasma gondii rhoptry protein 18 and microneme protein 8 provide enhanced protection. Vaccine. 2018. PMID: 30107996. doi:10.1016/j.vaccine.2018.08.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。